Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination

Journal of Surgical Oncology

Volumn 102, Issue 5, 2010, Pages 361-365

  Li, Chen ^a,b   Yan, Min ^a,b   Chen, Jun ^a,b   Xiang, Min ^a,b   Zhu, Zheng Gang ^a,b   Yin, Hao Ran ^a,b   Lin, Yan Zheng ^a,b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gastric cancer; Hyperthermic intraperitoneal chemotherapy; Peritoneal dissemination; Survival

Indexed keywords

CISPLATIN; MITOMYCIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHINA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; AGED; EVALUATION STUDY; GASTRECTOMY; HYPERTHERMIC THERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PERITONEUM TUMOR; REGIONAL PERFUSION; SECONDARY; STOMACH NEOPLASMS; SURVIVAL RATE;

AGED; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERITONEAL NEOPLASMS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 77957367085     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21628     Document Type: Article

References (24)

1. Li ZX, Kaminishi M: A comparison of gastric cancer between Japan and China. Gastric Cancer 2009;12:52-53.
2. Yang L, Parkin DM, Ferlay J, et al.: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005;14:243-250.
3. Zhang J, Wang XD, Chen ZC, et al.: Survival of patients with stomach cancer in Changle city of China. World J Gastroenterol 2004;10:1543-1546.
4. Hansson LE, Sparen P, Nyren O: Survival in stomach cancer is improving: Results of a nationwide population-based Swedish study. Ann Surg 1999;230:162-169. (Pubitemid 30191881)
5. Sano T, Katai H, Sasako M, et al.: The management of early gastric cancer. Surg Oncol 2000;9:17-22.
6. Sugarbaker PH: Peritonectomy procedures. Ann Surg 1995;221:29-42.
7. Elias D, Goere D, Blot F, et al.: Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43°C after complete cytoreductive surgery: Mortality and morbidity in 106 patients. Ann Surg Oncol 2007;14:1818-1824. (Pubitemid 46870938)
8. Glehen O, Schreiber V, Cotte E, et al.: Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004;139:20-26. (Pubitemid 38049613)
9. Kusamura S, Younan R, Baratti D, et al.: Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion. Cancer 2006;106:1144-1153.
10. Yonemura Y, Kawamura T, Bandou E, et al.: Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005;92:370-375. (Pubitemid 40445602)
11. Nakajima T: Gastric cancer treatment guidelines in Japan. Gastric Cancer 2002;5:1-5. (Pubitemid 34496345)
12. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English ed. Gastric Cancer 1998;1:10-24.
13. Fujisaki S, Tomita R, Nezu T, et al.: Prognostic studies on gastric cancer with concomitant liver metastases. Hepatogastroenterology 2001;48:892-894. (Pubitemid 32619707)
14. Li C, Yan M, Chen J, et al.: Prognostic influence of sub-stage according to pTNM category in patients with stage IV gastric cancer. J Surg Oncol 2009; 99: 324-328.
15. Takeno S, Noguchi T, Kikuchi R, et al.: Analysis of the survival period in resectable stage IV gastric cancer. Ann Surg Oncol 2001;8:215-221. (Pubitemid 32294801)
16. Yonemura Y, editor: Hyperthermo-chemotherapy for treatment of peritoneal carcinomatosis. In: Peritoneal dissemination-molecular mechanisms and the latest therapy. Kanazawa: Maeda Shoten; 1998; pp 237-260.
17. Choi EK, Park SR, Lee JH, et al.: Induction of apoptosis by carboplatin and hyperthermia alone or combined in WERI human retinoblastoma cells. Int J Hyperthermia 2003;19:431-443.
18. Ohtsubo T, Igawa H, Saito T, et al.: Enhancement of cell killing by induction of apoptosis after treatment with mild hyperthermia at 42°C and cisplatin. Radiat Res 2001;156:103-109. (Pubitemid 32641627)
19. Nakao K, Otsuki Y, Akao Y, et al.: The synergistic effects of hyperthermia and anticancer drugs on induction of apoptosis. Med Electron Microsc 2000;33:44-50.
20. Tang R, Zhu ZG, Qu Y, et al.: The impact of hyperthermic chemotherapy on human gastric cancer cell lines: Preliminary results. Oncol Rep 2006;16:631-641.
21. Sugarbaker PH: Review of a personal experience in the management of carcinomatosis and sarcomatosis. Jpn J Clin Oncol 2001;31:573-583. (Pubitemid 34116470)
22. Hall JJ, Loggie BW, Shen P, et al.: Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 2004;8:454-463. (Pubitemid 38561210)
23. Piso P, Slowik P, Popp F, et al.: Safety of Gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 2009;16:2188-2194.
24. Okabe H, Ueda S, Obama K, et al.: Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol 2009;16:3227-3236.